Applied DNA Sciences logo
Applied DNA Sciences APDN
$ 0.17 0.0%

Quarterly report 2024-Q2
added 08-08-2024

report update icon

Applied DNA Sciences Financial Ratios 2011-2024 | APDN

Annual Financial Ratios Applied DNA Sciences

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-1.5 -1.6 -1.9 -2.3 -0.0 -2.9 -5.2 -5.5 -5.5 -6.2 -5.2 -15.3 -2.5

P/S

1.1 0.7 3.1 15.6 0.0 8.5 14.0 16.1 7.2 29.7 44.9 59.0 27.2

EPS

-0.8 -0.9 -2.1 -3.3 -9.7 -15.9 -0.5 -0.5 -0.6 -1.0 -0.0 -0.0 -0.0

EV (Enterprise Value)

16.3 M 7.05 M 24.4 M 28.1 M 4.04 M 36.6 M 65.1 M 68 M 60.8 M 84.4 M 88.9 M 109 M 28.1 M

EBITDA per Share

-0.73 -1.41 -1.81 -3.13 -379 -15.1 -18.1 -19.4 -15.6 -35.1 -33.6 -25.8 -49

EV/EBITDA

-2.0 -2.0 -0.1 -3.0 -5.3 -5.5 -7.9 -6.9 -8.6 -17.6 -3.6

PEG

-0.0 -0.0 -0.0 0.05 0.0 -0.16 -1.32 -0.29 -0.16 -0.13 0.03 -0.23 0.05

P/B

3.0 1.0 2.5 5.3 -0.2 44.2 9.7 6.5 5.2 -55.0 19.8 144.6 -26.5

P/CF

-2.4 -1.4 -2.1 -2.5 -0.0 -4.6 -8.8 -6.3 -8.6 -9.2 -10.8 -26.5 -6.9

ROE %

-200.90 -64.03 -128.55 -228.17 1016.28 -1549.75 -187.45 -117.47 -94.54 889.81 -383.15 -944.71 1056.39

ROA %

-72.86 -37.13 -99.10 -114.87 -241.90 -207.55 -157.66 -78.22 -76.38 -372.69 -211.18 -530.10 -300.13

ROCE %

-221.23 -108.19 -120.11 -177.17 -691.89 -414.18 -186.93 -106.26 -60.94 3298.23 -140.17 -859.75 809.38

Current Ratio

1.6 2.4 4.4 2.1 1.0 1.4 4.8 2.8 4.3 0.6 6.5 1.9 0.7

DSO

45.4 59.0 60.6 36.7 56.9 138.9 198.8 555.8 159.2 112.0 120.6 58.4 78.6

DIO

21.7 27.4 75.0 251.8 59.3 67.0 110.6 145.6 - - - - -

DPO

65.6 52.2 130.9 632.9 479.2 151.5 129.8 748.1 - - - - -

Operating Cycle

67.1 86.4 135.6 288.5 116.2 205.9 309.4 701.4 - - - - -

Cash Conversion Cycle

1.5 34.2 4.7 -344.4 -363.0 54.4 179.7 -46.8 - - - - -

All numbers in USD currency

Quarterly Financial Ratios Applied DNA Sciences

2024-Q2 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

0.47 -0.09 - -4.8 0.05 -0.3 -0.94 -0.13 -0.23 -0.63 -1.45 -0.48 -0.21 -0.88 -2.54 -0.72 -0.79 -1.12 -8.46 -1.55 -1.12 -4.25 -0.28 -0.1 -0.11 -0.12 -0.38 -0.1 -0.12 -0.16 -0.41 -0.14 -0.16 -0.13 -0.63 -0.08 -0.13 -0.51 -0.82 -0.14 -0.51 -0.48 0.02 - -0.01 -0.01 -0.01 - -0.01 - -0.02 -0.01 -

EBITDA per Share

- -0.26 - - - -0.07 -0.67 -0.32 -0.27 -0.59 -1.23 -0.43 -0.29 -0.53 -2.36 -0.67 -0.77 -1.07 -8.04 -1.26 -1.07 -4.02 -0.26 -0.09 -0.1 -0.11 -0.36 -0.09 -0.11 -0.15 -0.39 -0.13 -0.15 -0.12 -0.39 -0.07 -0.12 -0.24 -0.68 -0.17 -0.24 -0.28 -0.01 - - - -0.01 - - - -0.01 - -

ROE %

-97.12 -106.76 -79.52 -138.42 -111.88 -140.42 -154.71 -183.77 -189.36 -174.49 -202.23 -269.99 -305.39 -348.87 -301.69 733.33 966.49 1334.56 949.16 -358.82 -956.68 -1695.34 -1312.24 -1029.40 -645.24 -262.14 -255.54 -203.88 -198.29 -197.39 -181.13 -177.56 -158.37 -143.44 -364.34 472.68 616.66 1173.06 1076.01 26.98 -149.97 -1017.31 -553.12 -961.75 -1104.36 -1920.16 -1872.10 -548.28 -142.90 1249.22 612.60 216.50 242.11

ROA %

-39.15 -47.54 -35.69 -69.85 -59.65 -75.20 -97.67 -131.32 -141.95 -139.80 -148.06 -158.77 -167.71 -183.22 -158.04 -287.09 -299.54 -348.21 -376.32 -226.17 -242.12 -224.83 -205.36 -270.61 -245.22 -226.85 -217.34 -157.39 -147.01 -133.41 -124.07 -134.56 -123.67 -117.04 -258.63 -498.07 -542.06 -746.54 -691.48 -545.63 -516.39 -393.92 -828.89 -1061.19 -1141.67 -1686.16 -1245.94 -1020.90 -976.43 -399.90 -174.04 -61.51 -68.78

ROCE %

-196.02 -196.14 -80.18 -154.53 -156.83 -157.88 -200.65 -205.44 -185.49 -169.75 -165.62 -234.81 -268.49 -308.05 -292.21 718.97 944.87 1307.21 926.08 -1021.04 -1565.36 -2292.95 -1914.72 -975.92 -639.68 -261.44 -254.89 -203.86 -198.93 -198.06 -181.84 -146.00 -126.29 -111.39 -210.82 489.88 672.55 955.76 868.88 57.31 -173.64 -636.16 -398.20 -855.02 -981.98 -1092.84 -994.38 61.87 400.21 895.69 429.95 149.79 182.08

Current Ratio

3.8 1.7 1.6 1.8 2.1 1.8 2.4 2.3 2.2 3.8 4.4 10.7 4.4 2.5 2.0 2.0 2.0 3.0 0.8 0.8 0.8 1.1 1.1 1.1 1.1 6.5 6.3 6.3 6.3 3.7 3.0 3.0 3.0 8.2 5.2 5.2 5.2 2.9 0.7 0.7 0.7 1.4 2.2 2.2 1.4 - 2.3 - - - - - -

DSO

55.2 36.2 - 41.5 62.3 61.7 18.5 57.8 47.8 73.0 27.0 95.0 65.5 34.7 11.0 41.1 13.2 80.2 20.6 37.3 104.8 108.4 50.1 133.4 159.2 334.2 65.5 131.4 440.6 633.1 228.1 891.0 520.4 270.6 71.3 158.1 173.8 71.6 36.7 90.6 58.2 108.6 47.0 100.6 84.9 94.6 17.3 51.3 76.1 38.9 27.7 82.9 -

DIO

70.0 48.9 - 17.8 14.8 17.1 8.1 36.2 33.8 39.9 31.9 73.5 92.8 92.1 80.1 293.2 109.1 44.3 23.3 48.0 72.3 132.8 21.1 80.0 159.2 88.2 37.0 128.2 89.5 103.1 36.9 150.5 49.4 - - - - - - - - - - - - - - - - - - - -

DPO

216.1 144.4 - 74.7 64.4 59.6 16.4 45.9 39.9 56.3 48.4 111.5 171.2 244.9 201.4 736.8 391.8 390.3 188.6 388.1 412.2 429.5 47.8 181.0 327.9 135.6 43.4 150.4 280.9 529.2 189.8 773.4 519.5 702.4 875.6 875.6 - - - - - - - - - - - - - - - - -

Operating Cycle

125.2 85.0 - 59.2 77.1 78.8 26.6 94.0 81.7 112.8 58.9 168.6 158.4 126.8 91.1 334.3 122.3 124.5 44.0 85.4 177.1 241.2 71.2 213.4 318.3 422.4 102.5 259.6 530.1 736.2 265.0 1041.5 569.8 270.6 71.3 158.1 173.8 71.6 36.7 90.6 58.2 108.6 47.0 100.6 84.9 94.6 17.3 51.3 76.1 38.9 27.7 82.9 -

Cash Conversion Cycle

-91.0 -59.4 - -15.5 12.7 19.2 10.2 48.1 41.8 56.5 10.5 57.1 -12.8 -118.1 -110.3 -402.6 -269.4 -265.8 -144.6 -302.7 -235.1 -188.4 23.4 32.4 -9.6 286.7 59.1 109.2 249.2 207.0 75.2 268.1 50.3 -431.8 -804.3 -717.5 173.8 71.6 36.7 90.6 58.2 108.6 47.0 100.6 84.9 94.6 17.3 51.3 76.1 38.9 27.7 82.9 -

All numbers in USD currency